NCT02493894

Brief Summary

Now a days, due to the change in lifestyle, the extended lifespan and the increase in the rate of the road accidents, the need for surgical operation of spinal instrumentation has been increased. And these surgeries are the most crucial part of neurological surgery wards. The everyday improvements in the quality of equipment used and advancements in surgical methods lead to best performance of these procedures and finally the higher quality of patients' lives. The procedures of Laminectomy and pedicular screw instrumentation lead to pain relief and better performance and developments in the quality of patients' lives. In addition to the above mentioned improvements, you must consider the fact that these activities are still accompanied by complications during and after surgical operation. Nerve root injury, Thecal sac tearing, injury to the spinal cord and the inappropriate sagittal balance are the most significant side effects during spinal surgery. One of the most important complications during and after these surgeries is perioperative bleeding that causes problems both for the patients and the surgeon.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P75+ for phase_1 surgery

Timeline
Completed

Started Jul 2014

Shorter than P25 for phase_1 surgery

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2015

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 10, 2015

Completed
Last Updated

July 10, 2015

Status Verified

July 1, 2015

Enrollment Period

10 months

First QC Date

June 18, 2015

Last Update Submit

July 7, 2015

Conditions

Keywords

Bowel preparationperioperative bleedinglumbar fusion

Outcome Measures

Primary Outcomes (1)

  • The volume of bleeding was measured in milliliter

    up to 3 days

Study Arms (2)

PEG & Cefazolin

EXPERIMENTAL

patients firstly get liquid diet for 24 hours. After that they get PEG solution (80gr/1Litr) each 8 hours for 24 hours. After 48 hours, cefazolin 1gram, every 6hours for 2 days

Drug: PEGDrug: Cefazolin

placebo & cefazolin

SHAM COMPARATOR

placebo for PEG and cefazolin 1gram, every 6hours for 2 days

Drug: placeboDrug: Cefazolin

Interventions

PEGDRUG

PEG solution (80gr/1Litr) each 8 hours for 24 hours

Also known as: PEG solution
PEG & Cefazolin

placebo each 8 hours for 24 hours

Also known as: sham
placebo & cefazolin

cefazolin 1gram, every 6hours for 2 days

Also known as: Kefzol
PEG & Cefazolinplacebo & cefazolin

Eligibility Criteria

Age33 Years - 82 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who suffer from lumbar spine degenerative disease and need spine fusion surgery.

You may not qualify if:

  • History of Trauma,
  • History of Malignancy,
  • previous spinal surgery,
  • History of coagulation disorder,
  • active infectious disease,
  • gastrointestinal problems,
  • severe movement disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alzahra Hospital

Isfahan, Isfahan, 81745319, Iran

Location

Related Publications (1)

  • Zhang F, Wang K, Li FN, Huang X, Li Q, Chen Z, Tang YB, Shen HX, Song QX. Effectiveness of tranexamic acid in reducing blood loss in spinal surgery: a meta-analysis. BMC Musculoskelet Disord. 2014 Dec 22;15:448. doi: 10.1186/1471-2474-15-448.

Related Links

MeSH Terms

Interventions

polyethylene glycol 3350salicylhydroxamic acidCefazolin

Intervention Hierarchy (Ancestors)

Cephalosporinsbeta-LactamsLactamsAmidesOrganic ChemicalsThiazinesSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Reza Abbasi, MD

    Alzahra University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Abbasi

Study Record Dates

First Submitted

June 18, 2015

First Posted

July 10, 2015

Study Start

July 1, 2014

Primary Completion

May 1, 2015

Study Completion

June 1, 2015

Last Updated

July 10, 2015

Record last verified: 2015-07

Locations